163 related articles for article (PubMed ID: 37024512)
21. Low incidence of sepsis due to viridans streptococci in a ten-year retrospective study of pediatric acute myeloid leukemia.
Brunet AS; Ploton C; Galambrun C; Pondarré C; Pages MP; Bleyzac N; Freydière AM; Barbé G; Bertrand Y
Pediatr Blood Cancer; 2006 Nov; 47(6):765-72. PubMed ID: 16333838
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the incidence, characteristics, and risk factors of complications during induction chemotherapy in children with high-risk neuroblastoma.
Du J; Yuan X
Eur J Pediatr; 2024 Jan; 183(1):185-202. PubMed ID: 37855927
[TBL] [Abstract][Full Text] [Related]
23. [Clinical characteristics and microbiological profile of viridans group streptococci bacteremia in children with cancer and high-risk febrile neutropenia].
Cortés D; Maldonado ME; Rivacoba MC; Maza V; Valenzuela R; Payá E; Contardo V; Álvarez AM; Avilés CL; Becker A; Salgado C; Tordecilla J; Varas M; Venegas M; Villarroel M; Viviani T; Zubieta M; Santolaya ME
Rev Chilena Infectol; 2020 Aug; 37(4):383-388. PubMed ID: 33399658
[TBL] [Abstract][Full Text] [Related]
24. Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients.
Gassas A; Grant R; Richardson S; Dupuis LL; Doyle J; Allen U; Abla O; Sung L
J Clin Oncol; 2004 Apr; 22(7):1222-7. PubMed ID: 15051769
[TBL] [Abstract][Full Text] [Related]
25. Incorporation of high-dose
Lee JW; Lee S; Cho HW; Ma Y; Yoo KH; Sung KW; Koo HH; Cho EJ; Lee SK; Lim DH
J Hematol Oncol; 2017 May; 10(1):108. PubMed ID: 28511709
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics and antibiotic susceptibility of viridans streptococcal bacteremia in children with febrile neutropenia.
Han SB; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK
Infection; 2013 Oct; 41(5):917-24. PubMed ID: 23640200
[TBL] [Abstract][Full Text] [Related]
27. Etiology and clinical course of febrile neutropenia in children with cancer.
Hakim H; Flynn PM; Knapp KM; Srivastava DK; Gaur AH
J Pediatr Hematol Oncol; 2009 Sep; 31(9):623-9. PubMed ID: 19644403
[TBL] [Abstract][Full Text] [Related]
28. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.
Bochud PY; Eggiman P; Calandra T; Van Melle G; Saghafi L; Francioli P
Clin Infect Dis; 1994 Jan; 18(1):25-31. PubMed ID: 8054434
[TBL] [Abstract][Full Text] [Related]
29. Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes.
Buckley SA; Othus M; Vainstein V; Abkowitz JL; Estey EH; Walter RB
Am J Hematol; 2014 Apr; 89(4):423-8. PubMed ID: 24382796
[TBL] [Abstract][Full Text] [Related]
30. Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country.
Ali N; Adil SN; Shaikh MU
Transpl Infect Dis; 2014 Feb; 16(1):98-105. PubMed ID: 24383473
[TBL] [Abstract][Full Text] [Related]
31. Etiology and Factors Affecting Severe Complications and Mortality of Febrile Neutropenia in Children with Acute Leukemia.
Erbaş İC; Çakıl Güzin A; Özdem Alataş Ş; Karaoğlu Asrak H; Akans İ; Akyol Ş; Özlü C; Tüfekçi Ö; Yılmaz Ş; Ören H; Belet N
Turk J Haematol; 2023 Aug; 40(3):143-153. PubMed ID: 37525503
[TBL] [Abstract][Full Text] [Related]
32. Clinical features of febrile neutropenia and bloodstream infection in autologous hematopoietic cell transplantation: Comparison to those in intensive chemotherapy for acute myeloid leukemia.
Yoshino N; Kimura SI; Matsuoka A; Meno T; Ishikawa T; Nakamura Y; Kawamura M; Takeshita J; Kawamura S; Misaki Y; Yoshimura K; Gomyo A; Okada Y; Tamaki M; Akahoshi Y; Kusuda M; Kameda K; Tanihara A; Wada H; Nakasone H; Kako S; Kanda Y
J Infect Chemother; 2023 Apr; 29(4):384-390. PubMed ID: 36669687
[TBL] [Abstract][Full Text] [Related]
33. Streptococcus pneumoniae bacteremia in patients with cancer: disease characteristics and outcomes in the era of escalating drug resistance (1998-2002).
Kumashi P; Girgawy E; Tarrand JJ; Rolston KV; Raad II; Safdar A
Medicine (Baltimore); 2005 Sep; 84(5):303-312. PubMed ID: 16148730
[TBL] [Abstract][Full Text] [Related]
34. Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study.
Raber-Durlacher JE; Laheij AM; Epstein JB; Epstein M; Geerligs GM; Wolffe GN; Blijlevens NM; Donnelly JP
Support Care Cancer; 2013 Jun; 21(6):1621-7. PubMed ID: 23288398
[TBL] [Abstract][Full Text] [Related]
35. Three cases of viridans group streptococcal bacteremia in children with febrile neutropenia and literature review.
Danilatou V; Mantadakis E; Galanakis E; Christidou A; Stiakaki E; Kalmanti M
Scand J Infect Dis; 2003; 35(11-12):873-6. PubMed ID: 14723365
[TBL] [Abstract][Full Text] [Related]
36. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance.
Bruckner L; Gigliotti F
Semin Pediatr Infect Dis; 2006 Jul; 17(3):153-60. PubMed ID: 16934710
[TBL] [Abstract][Full Text] [Related]
37. Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases.
Kern W; Kurrle E; Schmeiser T
Infection; 1990; 18(3):138-45. PubMed ID: 2365465
[TBL] [Abstract][Full Text] [Related]
38. Incidence of bacteremias and invasive mycoses in children with high risk neuroblastoma.
Castagnola E; Conte M; Parodi S; Papio F; Caviglia I; Haupt R
Pediatr Blood Cancer; 2007 Oct; 49(5):672-7. PubMed ID: 17039488
[TBL] [Abstract][Full Text] [Related]
39. Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol - a prospective nationwide study.
Kolonen A; Sinisalo M; Huttunen R; Syrjänen J; Aittoniemi J; Huhtala H; Sankelo M; Rintala H; Räty R; Jantunen E; Nousiainen T; Säily M; Kauppila M; Itälä-Remes M; Ollikainen H; Rauhala A; Koistinen P; Elonen E;
Infect Dis (Lond); 2017; 49(11-12):799-808. PubMed ID: 28683646
[TBL] [Abstract][Full Text] [Related]
40. Rapid COJEC versus standard induction therapies for high-risk neuroblastoma.
Peinemann F; Tushabe DA; van Dalen EC; Berthold F
Cochrane Database Syst Rev; 2015 May; 2015(5):CD010774. PubMed ID: 25989478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
